Role of prostaglandin D2 and the autonomic nervous system in niacin-induced flushing

Journal of Diabetes

Volumn 5, Issue 1, 2013, Pages 59-67

  Parson, Henri K ^a   Harati, Hadi ^a   Cooper, Deona ^a   Vinik, Aaron I ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Autonomic nervous system; Flushing; Niacin; Prostaglandin D2

Indexed keywords

ACETYLSALICYLIC ACID; NICOTINIC ACID; PROSTAGLANDIN D2;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BODY MASS; CHOLESTEROL BLOOD LEVEL; FEMALE; FLUSHING; GLABROUS SKIN; HUMAN; HUMAN EXPERIMENT; HYPERPNEA; LIMIT OF DETECTION; MALE; NORMAL HUMAN; PARASYMPATHETIC TONE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PRURITUS; SKIN BLOOD FLOW; SKIN TEMPERATURE; VALSALVA MANEUVER; VASODILATATION; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM; FEMALE; FLUSHING; HUMANS; MALE; MIDDLE AGED; NIACIN; PROSTAGLANDIN D2; REFERENCE VALUES;

MLCS; MLOWN;

EID: 84873428570     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2012.00216.x     Document Type: Article

References (26)

1. Vinik AI, Woltering EA, Warner RR et al.NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas. 2010; 39: 713-34.
2. 2 in vivo in humans following the administration of nicotinic acid. Prostaglandins. 1989; 38: 263-74.
3. 2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci USA. 2006; 103: 6682-7.
4. Kawata AK, Revicki DA, Thakkar R et al.Flushing ASsessment Tool (FAST): Psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy. Clin Drug Invest. 2009; 29: 215-29.
5. Jacobson TA. A "hot" topic in dyslipidemia management: "How to beat a flush". Optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention. Mayo Clin Proc. 2010; 85: 365-79.
6. Cefali EA, Simmons PD, Stanek EJ, McGovern ME, Kissling CJ. Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation. Int J Clin Pharmacol Ther. 2007; 45: 78-88.
7. Thakkar RB, Kashyap ML, Lewin AJ, Krause SL, Jiang P, Padley RJ. Acetylsalicylic acid reduces niacin extended-release-induced flushing in patients with dyslipidemia. Am J Cardiovasc Drugs. 2009; 9: 69-79.
8. Benyo Z, Gille A, Kero J et al.GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest. 2005; 115: 3634-40.
9. 2 release following oral administration of niacin in humans. J Invest Dermatol. 1992; 98: 812-5.
10. Kamanna VS, Ganji SH, Kashyap ML. The mechanism and mitigation of niacin-induced flushing. Int J Clin Pract. 2009; 63: 1369-77.
11. Vinik AI, Erbas T, Park TS. Methods for evaluation of peripheral neurovascular dysfunction. Diabetes Technol Ther. 2001; 3: 29-50.
12. Vinik AI, Maser RE, Ziegler D. Neuropathy: The crystal ball for cardiovascular disease?Diabetes Care. 2010; 33: 1688-90.
13. Vinik A, Erbas T, Park T, Stansberry K, Scanelli J, Pittenger G. Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care. 2001; 24: 1468-75.
14. Agelink MW, Malessa R, Baumann B et al.Standardized tests of heart rate variability: Normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res. 2001; 11: 99-108.
15. Bowsher D, Geoffrey WC, Nicholas AK et al.Absence of pain with hyperhidrosis: A new syndrome where vascular afferents may mediate cutaneous sensation. Pain. 2009; 147: 287-98.
16. Vinik AI, Freeman R, Erbas T. Diabetic autonomic neuropathy. In: Porte D, Sherwin RS, Baron A (eds). Ellenberg & Rifkin Diabetes Mellitus, 6th edn. McGraw-Hill, New York, 2003; 789-804.
17. Dzeka TN, Townley R, Arnold JM. Effects of enalaprilat on venoconstriction to norepinephrine: Role of prostaglandins. Cardiovasc Res. 2003; 59: 250-6.
18. Whelan AM, Price SO, Fowler SF, Hainer BL. The effect of aspirin on niacin-induced cutaneous reactions. J Fam Pract. 1992; 34: 165-8.
19. 2 receptor subtype 1. Clin Pharmacol Ther. 2007; 81: 849-57.
20. Hanson J, Gille A, Zwykiel S et al.Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. J Clin Invest. 2010; 120: 2910-9.
21. Kamanna VS, Vo A, Kashyap ML. Nicotinic acid: Recent developments. Curr Opin Cardiol. 2008; 23: 393-8.
22. Saareks V, Ylitalo P, Mucha I, Riutta A. Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. Pharmacol Toxicol. 2002; 90: 338-42.
23. 2 from mast cells and serotonin from platelets: Evidence from human cells in vitro and an animal model. J Pharmacol Exp Ther. 2008; 327: 665-72.
24. Vinik A. Barely scratching the surface. Diabetes Care. 2010; 33: 210-2.
25. Yamaoka H, Sasaki H, Yamasaki H et al.Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care. 2010; 33: 150-5.
26. Aronson D, Burger AJ. Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure. Ann Noninvasive Electrocardiol. 2001; 6: 98-106.